- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Castrate-Resistant Prostate Cancer
Total 5631 results
-
BayerRecruitingNon-metastatic Castration-resistant Prostate CancerIndia
-
British Columbia Cancer AgencyRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Canada
-
AstraZenecaCompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Advanced Accelerator ApplicationsNo longer availableMetastatic Castration-resistant Prostate Cancer (mCRPC)
-
Taro Iguchi, MD, PHDBayer Yakuhin, Ltd.Active, not recruitingBone Metastases | Castration-resistant Prostate CancerJapan
-
University of WashingtonJanssen Research & Development, LLCTerminatedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Double-Negative Prostate CarcinomaUnited States
-
MediLink Therapeutics (Suzhou) Co., Ltd.RecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)China
-
DendreonNot yet recruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Spain, France
-
OncoC4, Inc.Prostate Cancer Clinical Trials ConsortiumRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
BayerActive, not recruitingBone Metastatic Castration-resistant Prostate CancerFrance, Lithuania, Israel, Italy, United Kingdom, Austria
-
FutureChemActive, not recruitingMetastatic Castration-resistant Prostate Cancer, mCRPCKorea, Republic of
-
Accutar Biotechnology IncTerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaSuspendedPidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer (REPAIR)Metastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate Cancer (CRPC)United States, Moldova, Republic of, South Africa
-
Istituto Scientifico Romagnolo per lo Studio e...TerminatedMetastatic Castration Resistant Prostate Cancer (mCRPC)Italy
-
Centre Francois BaclesseGIRCI (French Interregional Group of Clinical Research and Innovation); Ligue...TerminatedMetastasis | Castration-resistant Prostate CancerFrance
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer
-
OHSU Knight Cancer InstituteMerck Sharp & Dohme LLC; Oregon Health and Science University; Collins Medical...Active, not recruitingCastration-Resistant Prostate Carcinoma | Recurrent Prostate Carcinoma | PSA Progression | Hormone-Resistant Prostate Cancer | Stage IV Prostate Adenocarcinoma Cancer AJCC v8United States
-
UNICANCERInstitut Bergonié; National Cancer Institute, France; Institut du Cancer de Montpellier...CompletedChemotherapy | Castration-resistant Prostate Cancer | Prostate Carcinoma | Circulating Tumor CellsFrance
-
Michael Graham PhD, MDUniversity of Iowa; Holden Comprehensive Cancer CenterActive, not recruitingProstate Cancer | Prostatic Neoplasms, Castration-Resistant | Prostatic Neoplasm | Prostatic Cancer Recurrent | Prostatic Cancer MetastaticUnited States
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
SL VAXiGENRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)Korea, Republic of
-
Yantai LNC Biotechnology Singapore PTE. LTD.Not yet recruitingMetastatic Castration-resistant Prostate Cancer, mCRPC
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-resistant Prostate Cancer (mCRPC)Australia, Germany, United States, Puerto Rico, Israel, Korea, Republic of, Taiwan, China, Costa Rica, Guatemala, Spain, France, Hong Kong, Portugal, Romania, Chile, Czechia, Hungary, Italy, Sweden, Turkey, United Kingdom, Estonia, Ir... and more
-
University of OklahomaDendreonRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration-resistant Prostate Cancer | mCRPCAustralia
-
Fudan UniversityRecruitingProstate Cancer | Castration-resistant Prostate Cancer | Metastatic DiseaseChina
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
BayerActive, not recruitingNon-metastatic Castration-resistant Prostate CancerUnited States
-
BayerActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States, United Kingdom, Finland
-
BayerCompletedNon-metastatic Castration-resistant Prostate CancerUnited States
-
Accutar Biotechnology IncTerminatedMetastatic Castration Resistant Prostate CancerChina
-
Allarity TherapeuticsSmerud Medical Research International AS; Lantern Pharma Inc.Active, not recruitingIrofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Metastatic Castration-Resistant Prostate Cancer PatientsDenmark
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKline; University of WashingtonCompletedProstate Cancer | Castration-resistant, MetastaticUnited States
-
National Cancer Institute (NCI)TerminatedCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
Rana McKay, MDBristol-Myers Squibb; ExelixisRecruitingMetastatic Cancer | Castration-resistant Prostate CancerUnited States
-
PfizerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC) | Metastatic Castration Sensitive Prostate Cancer (mCSPC)Finland
-
University of WashingtonNational Cancer Institute (NCI)CompletedMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Hormone-Resistant Prostate Cancer | Stage IV Prostate AdenocarcinomaUnited States
-
Thomas HopeGateway for Cancer Research; Prostate Cancer Foundation; Conquer Cancer FoundationActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
Jonsson Comprehensive Cancer CenterRecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Emory UniversityCompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7United States
-
Xencor, Inc.RecruitingMetastatic Castration-Resistant Prostate CancerUnited States
-
BayerActive, not recruitingCastration-resistant Prostate CancerTaiwan
-
University Hospital, Basel, SwitzerlandNot yet recruitingCastration-resistant Prostate CancerSwitzerland
-
Novartis PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)France
-
Sidney Kimmel Comprehensive Cancer Center at Johns...United States Department of DefenseRecruitingCastration Resistant Metastatic Prostate CancerUnited States
-
Noxopharm LimitedTerminatedMetastatic Castration-resistant Prostate Cancer and Other Solid TumorsUnited States
-
University of WashingtonNational Cancer Institute (NCI)WithdrawnMicrosatellite Instability | Hormone-Resistant Prostate Cancer | Castration Levels of TestosteroneUnited States